Last reviewed · How we verify

NCT03485586: PPV

Comparison of the Visual Quality of Traditional Ultrasound Biometrics and Lenstar on the Cataract After Pars Plana Vitrectomy

Status unknown Last updated 3 April 2018
What this trial tests

trial testing Traditional ultrasound biometrics in Diabetic Retinopathy Patients After Vitrectomy in 60 participants. Status unknown.

Timeline
3 April 2018
Primary endpoint
31 July 2018
31 October 2018

Quick facts

Lead sponsorBojie Hu
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment60
Start date3 April 2018
Primary completion31 July 2018
Estimated completion31 October 2018
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

Bojie Hu — full company profile →

Who can join

Eligibility, any sex, with Diabetic Retinopathy Patients After Vitrectomy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Comparison of the visual quality of traditional ultrasound biometrics and lenstar on the cataract patients with diabetic retinopathy after vitrectomy in the 3 months later.To evaluate the clinical value of lenstar in post-vitrectomy patients.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Bojie Hu trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03485586.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing